{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:03:32Z","timestamp":1777521812771,"version":"3.51.4"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Utilizing naringenin as a safe, natural compound for reducing graphene oxide and to determine whether Nar-RGO more effectively mitigates the harmful effects of HFFD-induced NAFLD compared to crude naringenin. Using a straightforward experimental setup, we utilize the bioactive flavonoid naringenin (NAR) as the reducing agent to synthesize naringenin-reduced graphene oxide nanosheets (Nar-RGO). Naringenin loading on graphene oxide was validated using electroscopic methods\u00a0(SEM and TEM) and zeta potential measurements. Utilization of reduced graphene oxide for naringenin encapsulation resulted in a significant improvement in hepatic steatosis, insulin resistance, oxidative stress, and signs of inflammation in HFFD-induced NAFLD compared to crude naringenin. This study demonstrates that Nar-RGO exhibits significantly greater efficacy compared to free naringenin. Therefore, it can be used as a promising medicine in counteracting\u00a0high-fat-fructose diet (HFFD)-induced NAFLD.<\/jats:p>","DOI":"10.1007\/s00210-024-03495-9","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T16:01:37Z","timestamp":1729094497000},"page":"4071-4086","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Possible protective effect of natural flavanone naringenin-reduced graphene oxide nanosheets on nonalcoholic fatty liver disease"],"prefix":"10.1007","volume":"398","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4910-1027","authenticated-orcid":false,"given":"Doaa","family":"Abdelmoneim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehab B.","family":"Eldomany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"El-Adl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Farghali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gehad","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El Said","family":"El-Sherbini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"issue":"10","key":"3495_CR1","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.3748\/wjg.v22.i10.2931","volume":"22","author":"EA Abd El-Haleim","year":"2016","unstructured":"Abd El-Haleim EA, Bahgat AK, Saleh S (2016) Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression. World J Gastroenterol 22(10):2931","journal-title":"World J Gastroenterol"},{"key":"3495_CR2","doi-asserted-by":"publisher","first-page":"127018","DOI":"10.1016\/j.cej.2020.127018","volume":"405","author":"V Agarwal","year":"2021","unstructured":"Agarwal V, Zetterlund PB (2021) Strategies for reduction of graphene oxide\u2013A comprehensive review. Chem Eng J 405:127018","journal-title":"Chem Eng J"},{"issue":"3","key":"3495_CR3","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3390\/gastroent15030042","volume":"15","author":"H Aghara","year":"2024","unstructured":"Aghara H, Chadha P, Mandal P (2024) Mitigative effect of graphene oxide nanoparticles in maintaining gut\u2013liver homeostasis against alcohol injury. Gastroenterol Insights 15(3):574\u2013587","journal-title":"Gastroenterol Insights"},{"issue":"6","key":"3495_CR4","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3390\/life12060790","volume":"12","author":"AA Ajah","year":"2022","unstructured":"Ajah AA, Lembede BW, Nkomozepi P, Erlwanger KH, Nyakudya TT (2022) Neonatal oral administration of chrysin prevents long-term development of non-alcoholic fatty liver disease in a sexually dimorphic manner in fructose nurtured Sprague Dawley Rats. Life 12(6):790","journal-title":"Life"},{"issue":"1","key":"3495_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40360-021-00524-8","volume":"22","author":"R Akbari","year":"2021","unstructured":"Akbari R, Behdarvand T, Afarin R, Yaghooti H, Jalali MT, Mohammadtaghvaei N (2021) Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis. BMC Pharmacol Toxicol 22(1):1\u20139","journal-title":"BMC Pharmacol Toxicol"},{"issue":"4","key":"3495_CR6","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/clinchem\/20.4.470","volume":"20","author":"CC Allain","year":"1974","unstructured":"Allain CC, Poon LS, Chan CS, Richmond W, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20(4):470\u2013475","journal-title":"Clin Chem"},{"key":"3495_CR7","doi-asserted-by":"crossref","unstructured":"Amir Siddiqui M, Badruddeen AJ, Uddin S, Chandrashekharan SM, Ahmad M, ... Khalid M (2022) Chrysin modulates protein kinase IKK\u03b5\/TBK1, insulin sensitivity and hepatic fatty infiltration in diet\u2010induced obese mice. Drug Dev Res 83(1):194-207","DOI":"10.1002\/ddr.21859"},{"key":"3495_CR8","doi-asserted-by":"crossref","unstructured":"An W, Zhang Y, Zhang X, Li K, Kang Y, Akhtar S, ... Gao L (2018) Ocular toxicity of reduced graphene oxide or graphene oxide exposure in mouse eyes. Exp Eye Res 174:59\u201369","DOI":"10.1016\/j.exer.2018.05.024"},{"key":"3495_CR9","doi-asserted-by":"crossref","unstructured":"Arafah A, Rehman MU, Mir TM, Wali AF, Ali R, Qamar W, ... Alqahtani S (2020) Multi-therapeutic potential of naringenin (4\u2032, 5, 7-trihydroxyflavonone): experimental evidence and mechanisms. Plants 9(12):1784","DOI":"10.3390\/plants9121784"},{"key":"3495_CR10","doi-asserted-by":"crossref","unstructured":"Attia H, Albekairi N, Albdeirat L, Soliman A, Rajab R, Alotaibi H, ... Badr A (2022) Chrysin attenuates fructose-induced nonalcoholic fatty liver in rats via antioxidant and anti-inflammatory effects: the role of angiotensin-converting enzyme 2\/angiotensin (1\u20137)\/Mas Receptor Axis. Oxidative Med Cell Longev 2022:1-14","DOI":"10.1155\/2022\/9479456"},{"issue":"4","key":"3495_CR11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/bios12040244","volume":"12","author":"I Badillo-Ram\u00edrez","year":"2022","unstructured":"Badillo-Ram\u00edrez I, Carre\u00f3n YJ, Rodr\u00edguez-Almaz\u00e1n C, Medina-Dur\u00e1n CM, Islas SR, Saniger JM (2022) Graphene-based biosensors for molecular chronic inflammatory disease biomarker detection. Biosensors 12(4):244","journal-title":"Biosensors"},{"key":"3495_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.memsci.2018.03.006","volume":"554","author":"F Baskoro","year":"2018","unstructured":"Baskoro F, Wong C-B, Kumar SR, Chang C-W, Chen C-H, Chen DW, Lue SJ (2018) Graphene oxide-cation interaction: inter-layer spacing and zeta potential changes in response to various salt solutions. J Membr Sci 554:253\u2013263","journal-title":"J Membr Sci"},{"key":"3495_CR13","doi-asserted-by":"crossref","unstructured":"Beiriger J, Chauhan K, Khan A, Shahzad T, Parra NS, Zhang P, ... Bruckbauer J (2023) Advancements in understanding and treating NAFLD: a comprehensive review of metabolic-associated fatty liver disease and emerging therapies. Livers 3(4):637\u2013656","DOI":"10.3390\/livers3040042"},{"key":"3495_CR14","doi-asserted-by":"crossref","unstructured":"Bellet P, Gasparotto M, Pressi S, Fortunato A, Scapin G, Mba M, ... Filippini F (2021) Graphene-based scaffolds for regenerative medicine. Nanomaterials 11(2):404","DOI":"10.3390\/nano11020404"},{"key":"3495_CR15","doi-asserted-by":"crossref","unstructured":"Bhia M, Motallebi M, Abadi B, Zarepour A, Pereira-Silva M, Saremnejad F, ... Jafari SM (2021) Naringenin nano-delivery systems and their therapeutic applications. Pharmaceutics 13(2):291","DOI":"10.3390\/pharmaceutics13020291"},{"issue":"2","key":"3495_CR16","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/EJE-16-0488","volume":"176","author":"C Br\u00f8ns","year":"2017","unstructured":"Br\u00f8ns C, Grunnet LG (2017) Mechanisms in endocrinology: skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes: a causal mechanism or an innocent bystander? Eur J Endocrinol 176(2):R67\u2013R78","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"3495_CR17","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.3390\/biomedicines11072071","volume":"11","author":"J Buniam","year":"2023","unstructured":"Buniam J, Chansela P, Weerachayaphorn J, Saengsirisuwan V (2023) Dietary supplementation with 20-hydroxyecdysone ameliorates hepatic steatosis and reduces white adipose tissue mass in ovariectomized rats fed a high-fat, high-fructose diet. Biomedicines 11(7):2071","journal-title":"Biomedicines"},{"issue":"1","key":"3495_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.livres.2020.02.004","volume":"4","author":"H Chen","year":"2020","unstructured":"Chen H (2020) Nutrient mTORC1 signaling contributes to hepatic lipid metabolism in the pathogenesis of non-alcoholic fatty liver disease. Liver Res 4(1):15\u201322","journal-title":"Liver Res"},{"issue":"2","key":"3495_CR19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/clinchem\/44.2.354","volume":"44","author":"D Chevenne","year":"1998","unstructured":"Chevenne D, Letailleur A, Trivin F, Porquet D (1998) Effect of hemolysis on the concentration of insulin in serum determined by RIA and IRMA. Clin Chem 44(2):354\u2013356","journal-title":"Clin Chem"},{"key":"3495_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00394-010-0117-8","volume":"50","author":"KW Cho","year":"2011","unstructured":"Cho KW, Kim YO, Andrade JE, Burgess JR, Kim Y-C (2011) Dietary naringenin increases hepatic peroxisome proliferators\u2013activated receptor \u03b1 protein expression and decreases plasma triglyceride and adiposity in rats. Eur J Nutr 50:81\u201388","journal-title":"Eur J Nutr"},{"issue":"14","key":"3495_CR21","doi-asserted-by":"publisher","first-page":"4916","DOI":"10.1039\/D2BM01791A","volume":"11","author":"S de Frutos","year":"2023","unstructured":"de Frutos S, Griera M, del Prado Lav\u00edn-L\u00f3pez M, Mart\u00ednez-Rovira M, Mart\u00ednez-Rovira JA, Rodr\u00edguez-Puyol M, Rodr\u00edguez-Puyol D (2023) A new graphene-based nanomaterial increases lipolysis and reduces body weight gain through integrin linked kinase (ILK). Biomater Sci 11(14):4916\u20134929","journal-title":"Biomater Sci"},{"key":"3495_CR22","doi-asserted-by":"crossref","unstructured":"Di Mauro G, Amoriello R, Lozano N, Carnasciali A, Guasti D, Becucci M, ... Ballerini L (2023) Graphene oxide nanosheets reduce astrocyte reactivity to inflammation and ameliorate experimental autoimmune encephalomyelitis. ACS Nano 17(3):1965\u20131978","DOI":"10.1021\/acsnano.2c06609"},{"key":"3495_CR23","doi-asserted-by":"crossref","unstructured":"Dos Santos FKF, J\u00fanior AAMP, Filho ALN, Fonseca CJN, Isidorio DKM, Ara\u00fajo FdA, ... Veiga J\u00fanior VFd (2024) Graphene and natural products: a review of antioxidant properties in graphene oxide reduction. Int J Mol Sci 25(10):5182","DOI":"10.3390\/ijms25105182"},{"key":"3495_CR24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0076-6879(90)86135-I","volume":"186","author":"HH Draper","year":"1990","unstructured":"Draper HH, Hadley M (1990) Malondialdehyde determination as index of lipid Peroxidation. Methods Enzymol 186:421\u2013431 (Elsevier)","journal-title":"Methods Enzymol"},{"issue":"3","key":"3495_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/flgastro-2013-100403","volume":"5","author":"JK Dyson","year":"2014","unstructured":"Dyson JK, Anstee QM, McPherson S (2014) Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontline Gastroenterol 5(3):211\u2013218","journal-title":"Frontline Gastroenterol"},{"key":"3495_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10238-012-0227-0","volume":"14","author":"NK Gatselis","year":"2014","unstructured":"Gatselis NK, Ntaios G, Makaritsis K, Dalekos GN (2014) Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease. Clin Exp Med 14:121\u2013131","journal-title":"Clin Exp Med"},{"issue":"5","key":"3495_CR27","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1021\/acsanm.0c00630","volume":"3","author":"S Gnanasekar","year":"2020","unstructured":"Gnanasekar S, Balakrishnan D, Seetharaman P, Arivalagan P, Chandrasekaran R, Sivaperumal S (2020) Chrysin-anchored silver and gold nanoparticle-reduced graphene oxide composites for breast cancer therapy. ACS Applied Nano Materials 3(5):4574\u20134585","journal-title":"ACS Applied Nano Materials"},{"key":"3495_CR28","doi-asserted-by":"crossref","unstructured":"Gomes MGd, Kemmerich M, Deus Cd, Menezes CRd (2023) Chrysin flavonoid encapsulation: a review about methodologies used and biological potential. Ci\u00eancia Rural 54:e20230067","DOI":"10.1590\/0103-8478cr20230067"},{"key":"3495_CR29","doi-asserted-by":"publisher","first-page":"9990091","DOI":"10.1155\/2021\/9990091","volume":"2021","author":"RA Hassan","year":"2021","unstructured":"Hassan RA, Hozayen WG, Abo Sree HT, Al-Muzafar HM, Amin KA, Ahmed OM (2021) Naringin and hesperidin counteract diclofenac-induced hepatotoxicity in male wistar rats via their antioxidant, anti-inflammatory, and antiapoptotic activities. Oxidative Med Cell Longev 2021:9990091","journal-title":"Oxidative Med Cell Longev"},{"issue":"16","key":"3495_CR30","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.3748\/wjg.v24.i16.1679","volume":"24","author":"E Hern\u00e1ndez-Aquino","year":"2018","unstructured":"Hern\u00e1ndez-Aquino E, Muriel P (2018) Beneficial effects of naringenin in liver diseases: molecular mechanisms. World J Gastroenterol 24(16):1679","journal-title":"World J Gastroenterol"},{"issue":"4","key":"3495_CR31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R (2021) Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 18(4):223\u2013238","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3495_CR32","doi-asserted-by":"crossref","unstructured":"Kanchanapally R, Nellore BPV, Sinha SS, Pedraza F, Jones SJ, Pramanik A, ... Vangara A (2015) Antimicrobial peptide-conjugated graphene oxide membrane for efficient removal and effective killing of multiple drug resistant bacteria. RSC Adv 5(24):18881\u201318887","DOI":"10.1039\/C5RA01321F"},{"issue":"1","key":"3495_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/scipharm85010004","volume":"85","author":"FM Kandemir","year":"2017","unstructured":"Kandemir FM, Kucukler S, Eldutar E, Caglayan C, G\u00fcl\u00e7in \u0130 (2017) Chrysin protects rat kidney from paracetamol-induced oxidative stress, inflammation, apoptosis, and autophagy: a multi-biomarker approach. Sci Pharm 85(1):4","journal-title":"Sci Pharm"},{"key":"3495_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jconrel.2016.02.015","volume":"226","author":"SF Kiew","year":"2016","unstructured":"Kiew SF, Kiew LV, Lee HB, Imae T, Chung LY (2016) Assessing biocompatibility of graphene oxide-based nanocarriers: a review. J Control Release 226:217\u2013228","journal-title":"J Control Release"},{"issue":"11","key":"3495_CR35","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.3390\/ijms19113564","volume":"19","author":"C Liao","year":"2018","unstructured":"Liao C, Li Y, Tjong SC (2018) Graphene nanomaterials: synthesis, biocompatibility, and cytotoxicity. Int J Mol Sci 19(11):3564","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3495_CR36","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1159\/000524172","volume":"47","author":"H Liu","year":"2022","unstructured":"Liu H, Zhao H, Che J, Yao W (2022) Naringenin protects against hypertension by regulating lipid disorder and oxidative stress in a rat model. Kidney Blood Press Res 47(6):423\u2013432","journal-title":"Kidney Blood Press Res"},{"issue":"5","key":"3495_CR37","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/clinchem\/23.5.882","volume":"23","author":"MF Lopes-Virella","year":"1977","unstructured":"Lopes-Virella MF, Stone P, Ellis S, Colwell JA (1977) Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 23(5):882\u2013884","journal-title":"Clin Chem"},{"key":"3495_CR38","doi-asserted-by":"publisher","first-page":"109818","DOI":"10.1016\/j.eurpolymj.2020.109818","volume":"134","author":"S Maity","year":"2020","unstructured":"Maity S, Chakraborti AS (2020) Formulation, physico-chemical characterization and antidiabetic potential of naringenin-loaded poly D, L lactide-co-glycolide (N-PLGA) nanoparticles. Eur Polymer J 134:109818","journal-title":"Eur Polymer J"},{"issue":"3","key":"3495_CR39","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.18632\/oncotarget.14084","volume":"8","author":"MF Manchope","year":"2017","unstructured":"Manchope MF, Casagrande R, Verri WA Jr (2017) Naringenin: an analgesic and anti-inflammatory citrus flavanone. Oncotarget 8(3):3766","journal-title":"Oncotarget"},{"issue":"17","key":"3495_CR40","doi-asserted-by":"publisher","first-page":"e6770","DOI":"10.1097\/MD.0000000000006770","volume":"96","author":"JL Martin-Rodriguez","year":"2017","unstructured":"Martin-Rodriguez JL, Gonzalez-Cantero J, Gonzalez-Cantero A, Arrebola JP, Gonzalez-Calvin JL (2017) Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy. Medicine 96(17):e6770","journal-title":"Medicine"},{"key":"3495_CR41","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor B, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"issue":"4","key":"3495_CR42","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1021\/acsbiomaterials.9b01894","volume":"6","author":"Z Mohammadpour","year":"2020","unstructured":"Mohammadpour Z, Majidzadeh-A K (2020) Applications of two-dimensional nanomaterials in breast cancer theranostics. ACS Biomater Sci Eng 6(4):1852\u20131873","journal-title":"ACS Biomater Sci Eng"},{"key":"3495_CR43","doi-asserted-by":"crossref","unstructured":"Murugan R, Mukesh G, Haridevamuthu B, Priya PS, Pachaiappan R, Almutairi BO, ... Arockiaraj J (2023) Plausible antioxidant and anticonvulsant potential of brain targeted naringenin-conjugated graphene oxide nanoparticles. Biomass Convers Biorefinery 14:1\u201312","DOI":"10.1007\/s13399-023-04343-1"},{"key":"3495_CR44","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0006-291X(72)80218-3","volume":"46","author":"M Nishikimi","year":"1972","unstructured":"Nishikimi M, Roa N, Yogi K (1972) Measurement of superoxide dismutase. Biochem Biophys Res Commun 46:849\u2013854","journal-title":"Biochem Biophys Res Commun"},{"key":"3495_CR45","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s11901-018-0425-7","volume":"17","author":"M Noureddin","year":"2018","unstructured":"Noureddin M, Sanyal AJ (2018) Pathogenesis of NASH: the impact of multiple pathways. Curr Hepatol Rep 17:350\u2013360","journal-title":"Curr Hepatol Rep"},{"key":"3495_CR46","doi-asserted-by":"publisher","first-page":"101122","DOI":"10.1016\/j.molmet.2020.101122","volume":"50","author":"K Pafili","year":"2021","unstructured":"Pafili K, Roden M (2021) Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans. Mol Metab 50:101122","journal-title":"Mol Metab"},{"issue":"1","key":"3495_CR47","first-page":"158","volume":"70","author":"DE Paglia","year":"1967","unstructured":"Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70(1):158\u2013169","journal-title":"J Lab Clin Med"},{"key":"3495_CR48","doi-asserted-by":"publisher","first-page":"1323990","DOI":"10.3389\/fendo.2024.1323990","volume":"15","author":"H Qi","year":"2024","unstructured":"Qi H, Wang B, Zhu L (2024) Independent associations of serum calcium with or without albumin adjustment and serum phosphorus with nonalcoholic fatty liver disease: results from NHANES 1999\u20132018. Front Endocrinol 15:1323990","journal-title":"Front Endocrinol"},{"issue":"20","key":"3495_CR49","doi-asserted-by":"publisher","first-page":"11744","DOI":"10.1039\/C4NR03275F","volume":"6","author":"Y Qiu","year":"2014","unstructured":"Qiu Y, Wang Z, Owens AC, Kulaots I, Chen Y, Kane AB, Hurt RH (2014) Antioxidant chemistry of graphene-based materials and its role in oxidation protection technology. Nanoscale 6(20):11744\u201311755","journal-title":"Nanoscale"},{"issue":"1","key":"3495_CR50","first-page":"76","volume":"7","author":"R Rashmi","year":"2018","unstructured":"Rashmi R, Magesh SB, Ramkumar KM, Suryanarayanan S, SubbaRao MV (2018) Antioxidant potential of naringenin helps to protect liver tissue from streptozotocin-induced damage. Rep Biochem Mol Biol 7(1):76","journal-title":"Rep Biochem Mol Biol"},{"key":"3495_CR51","doi-asserted-by":"publisher","first-page":"634344","DOI":"10.3389\/fphar.2021.634344","volume":"12","author":"E Roeb","year":"2021","unstructured":"Roeb E, Weiskirchen R (2021) Fructose and non-alcoholic steatohepatitis. Front Pharmacol 12:634344","journal-title":"Front Pharmacol"},{"key":"3495_CR52","unstructured":"Rosita R, Yueniwati Y, Widjayanto E, Widodo MA, Handayani D, Endharti AT (2021) High fat high fructose diet elevates plasma level of HMGB1 due to non-alcoholic fatty liver disease (NAFLD). Ann Romanian Soc Cell Biol 25:5089\u20135095"},{"issue":"1","key":"3495_CR53","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/gutjnl-2016-312431","volume":"66","author":"Y Rotman","year":"2017","unstructured":"Rotman Y, Sanyal AJ (2017) Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease. Gut 66(1):180\u2013190","journal-title":"Gut"},{"key":"3495_CR54","doi-asserted-by":"crossref","unstructured":"Sadhukhan S, Ghosh TK, Rana D, Roy I, Bhattacharyya A, Sarkar G, ... Chattopadhyay D (2016) Studies on synthesis of reduced graphene oxide (RGO) via green route and its electrical property. Mater Res Bull 79:41\u201351","DOI":"10.1016\/j.materresbull.2016.02.039"},{"issue":"2","key":"3495_CR55","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.2042-7158.2010.01217.x","volume":"63","author":"S Sen","year":"2011","unstructured":"Sen S, Roy M, Chakraborti AS (2011) Ameliorative effects of glycyrrhizin on streptozotocin-induced diabetes in rats. J Pharm Pharmacol 63(2):287\u2013296","journal-title":"J Pharm Pharmacol"},{"issue":"4","key":"3495_CR56","first-page":"7013","volume":"9","author":"R Shanmuganathan","year":"2020","unstructured":"Shanmuganathan R, Sathishkumar G, Brindhadevi K, Pugazhendhi A (2020) Fabrication of naringenin functionalized-Ag\/RGO nanocomposites for potential bactericidal effects. J Market Res 9(4):7013\u20137019","journal-title":"J Market Res"},{"key":"3495_CR57","doi-asserted-by":"publisher","first-page":"132531","DOI":"10.1016\/j.foodchem.2022.132531","volume":"383","author":"N Shen","year":"2022","unstructured":"Shen N, Wang T, Gan Q, Liu S, Wang L, Jin B (2022) Plant flavonoids: classification, distribution, biosynthesis, and antioxidant activity. Food Chem 383:132531","journal-title":"Food Chem"},{"key":"3495_CR58","doi-asserted-by":"publisher","unstructured":"Sherif ZA (2019) The rise in the prevalence of nonalcoholic fatty liver disease and hepatocellular carcinoma. Nonalcoholic Fatty Liver Disease-An Update 1\u201322. https:\/\/doi.org\/10.5772\/intechopen.85780","DOI":"10.5772\/intechopen.85780"},{"issue":"11","key":"3495_CR59","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/jcs7110473","volume":"7","author":"MD Shirsat","year":"2023","unstructured":"Shirsat MD, Hianik T (2023) Electrochemical detection of heavy metal ions based on nanocomposite materials. J Compos Sci 7(11):473","journal-title":"J Compos Sci"},{"key":"3495_CR60","doi-asserted-by":"publisher","first-page":"1005312","DOI":"10.3389\/fphar.2022.1005312","volume":"13","author":"P Tan","year":"2022","unstructured":"Tan P, Jin L, Qin X, He B (2022) Natural flavonoids: potential therapeutic strategies for non-alcoholic fatty liver disease. Front Pharmacol 13:1005312","journal-title":"Front Pharmacol"},{"issue":"14","key":"3495_CR61","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMra0912063","volume":"363","author":"G Targher","year":"2010","unstructured":"Targher G, Day CP, Bonora E (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363(14):1341\u20131350","journal-title":"N Engl J Med"},{"issue":"4","key":"3495_CR62","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/bcpt.13944","volume":"133","author":"P Tveden-Nyborg","year":"2023","unstructured":"Tveden-Nyborg P, Bergmann TK, Jessen N, Simonsen U, Lykkesfeldt J (2023) BCPT 2023 policy for experimental and clinical studies. Basic Clin Pharmacol Toxicol 133(4):391\u2013396","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"3495_CR63","first-page":"1","volume":"6","author":"Y Wang","year":"2011","unstructured":"Wang Y, Liu J, Liu L, Sun DD (2011) High-quality reduced graphene oxide-nanocrystalline platinum hybrid materials prepared by simultaneous co-reduction of graphene oxide and chloroplatinic acid. Nanoscale Res Lett 6:1\u20138","journal-title":"Nanoscale Res Lett"},{"key":"3495_CR64","doi-asserted-by":"publisher","first-page":"113331","DOI":"10.1016\/j.biopha.2022.113331","volume":"153","author":"R Xu","year":"2022","unstructured":"Xu R, Pan J, Zhou W, Ji G, Dang Y (2022) Recent advances in lean NAFLD. Biomed Pharmacother 153:113331","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3495_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5530\/ajbls.2020.9.1","volume":"9","author":"M Yadav","year":"2020","unstructured":"Yadav M, Sehrawat N, Singh M, Upadhyay SK, Aggarwal D, Sharma AK (2020) Cardioprotective and hepatoprotective potential of citrus flavonoid naringin: Current status and future perspectives for health benefits. Asian J Biol Life Sci 9(1):1\u20135","journal-title":"Asian J Biol Life Sci"},{"issue":"11","key":"3495_CR66","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1016\/j.biomaterials.2013.01.001","volume":"34","author":"K Yang","year":"2013","unstructured":"Yang K, Gong H, Shi X, Wan J, Zhang Y, Liu Z (2013) In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration. Biomaterials 34(11):2787\u20132795","journal-title":"Biomaterials"},{"issue":"10","key":"3495_CR67","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR (2019) A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 16(10):589\u2013604","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3495_CR68","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1007\/s11010-021-04105-5","volume":"476","author":"S Yuvaraj","year":"2021","unstructured":"Yuvaraj S, Ramprasath T, Saravanan B, Vasudevan V, Sasikumar S, Selvam GS (2021) Chrysin attenuates high-fat-diet-induced myocardial oxidative stress via upregulating eNOS and Nrf2 target genes in rats. Mol Cell Biochem 476:2719\u20132727","journal-title":"Mol Cell Biochem"},{"key":"3495_CR69","doi-asserted-by":"crossref","unstructured":"Zaharia OP, Strassburger K, Strom A, B\u00f6nhof GJ, Karusheva Y, Antoniou S, ... M\u00fcssig K (2019) Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol 7(9):684\u2013694","DOI":"10.1016\/S2213-8587(19)30187-1"},{"key":"3495_CR70","doi-asserted-by":"crossref","unstructured":"Zhang H, Niu Y, Gu H, Lu S, Zhang W, Li X, ... Su Q (2019) Low serum adiponectin is a predictor of progressing to nonalcoholic fatty liver disease. J Clin Lab Anal 33(3):e22709","DOI":"10.1002\/jcla.22709"},{"key":"3495_CR71","doi-asserted-by":"crossref","unstructured":"Zhang H, Liu R, Wang J, Cui SW, Wang S, Wang B, ... Wang H (2023) Fabrication, characterization, and lipid-lowering effects of naringenin-zein-sodium caseinate-galactosylated chitosan nanoparticles. Int J Biol Macromol 230:123150","DOI":"10.1016\/j.ijbiomac.2023.123150"},{"issue":"20","key":"3495_CR72","doi-asserted-by":"publisher","first-page":"5618","DOI":"10.1021\/acs.jafc.1c01109","volume":"69","author":"Y-J Zhou","year":"2021","unstructured":"Zhou Y-J, Xu N, Zhang X-C, Zhu Y-Y, Liu S-W, Chang Y-N (2021) Chrysin improves glucose and lipid metabolism disorders by regulating the AMPK\/PI3K\/AKT signaling pathway in insulin-resistant HepG2 cells and HFD\/STZ-induced C57BL\/6J mice. J Agric Food Chem 69(20):5618\u20135627","journal-title":"J Agric Food Chem"},{"key":"3495_CR73","doi-asserted-by":"publisher","first-page":"956688","DOI":"10.3389\/fimmu.2022.956688","volume":"13","author":"J Zhou","year":"2022","unstructured":"Zhou J, Zhang N, Aldhahrani A, Soliman MM, Zhang L, Zhou F (2022) Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation. Front Immunol 13:956688","journal-title":"Front Immunol"},{"key":"3495_CR74","doi-asserted-by":"crossref","unstructured":"Zhou S, Li X, Zhu M, Yu H, Chu R, Chen W, ... Chai Z (2020) Hepatic impacts of gold nanoparticles with different surface coatings as revealed by assessing the hepatic drug-metabolizing enzyme and lipid homeostasis in mice. NanoImpact 20:100259","DOI":"10.1016\/j.impact.2020.100259"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03495-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03495-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03495-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T17:23:54Z","timestamp":1744219434000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03495-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3495"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03495-9","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]},"assertion":[{"value":"23 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the research ethical committee guidelines of the Faculty of Veterinary Medicine, Mansoura University, Mansoura, Egypt. Registry and the registration no. of the study: Ph.D\/84.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}